About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY

NCT07753356·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

MARCELO R OLIVA, MD
CONTACT
+541151409244 moliva.uba@gmail.com

Lead

Marcelo Ruben Oliva

Age

18–any

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Adult male patients with clinical suspicion of prostate cancer.
Patients scheduled to undergo multiparametric MRI-targeted prostate biopsy.
Signed informed consent.

You may not be if

Prior treatment for prostate cancer.
Contraindications to prostate biopsy or multiparametric MRI.

The record

StatusNot yet recruiting

PhaseNo phase

Taking part150

StartedAug 2026

UpdatedAug 7, 2026

Conditions

Prostate Cancer Prostatic Neoplasms/Diagnosis

Where1

Clinica Cemep
Rio Grande, Tierra del Fuego Province, Argentina